159 related articles for article (PubMed ID: 10346934)
1. A new method for rapidly generating inhibitors of glyoxalase I inside tumor cells using S-(N-aryl-N-hydroxycarbamoyl)ethylsulfoxides.
Hamilton DS; Kavarana MJ; Sharkey EM; Eiseman JL; Creighton DJ
J Med Chem; 1999 May; 42(10):1823-7. PubMed ID: 10346934
[TBL] [Abstract][Full Text] [Related]
2. Mechanism-based competitive inhibitors of glyoxalase I: intracellular delivery, in vitro antitumor activities, and stabilities in human serum and mouse serum.
Kavarana MJ; Kovaleva EG; Creighton DJ; Wollman MB; Eiseman JL
J Med Chem; 1999 Jan; 42(2):221-8. PubMed ID: 9925727
[TBL] [Abstract][Full Text] [Related]
3. Bivalent transition-state analogue inhibitors of human glyoxalase I.
Zheng ZB; Creighton DJ
Org Lett; 2003 Dec; 5(25):4855-8. PubMed ID: 14653691
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and antitumor properties in tumor-bearing mice of an enediol analogue inhibitor of glyoxalase I.
Sharkey EM; O'Neill HB; Kavarana MJ; Wang H; Creighton DJ; Sentz DL; Eiseman JL
Cancer Chemother Pharmacol; 2000; 46(2):156-66. PubMed ID: 10972486
[TBL] [Abstract][Full Text] [Related]
5. N-(2-hydroxypropyl)methacrylamide copolymers of a glutathione (GSH)-activated glyoxalase i inhibitor and DNA alkylating agent: synthesis, reaction kinetics with GSH, and in vitro antitumor activities.
Zheng ZB; Zhu G; Tak H; Joseph E; Eiseman JL; Creighton DJ
Bioconjug Chem; 2005; 16(3):598-607. PubMed ID: 15898727
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of S-(p-bromobenzyl)glutathione diesters in vitro: a structure-activity study.
Thornalley PJ; Ladan MJ; Ridgway SJ; Kang Y
J Med Chem; 1996 Aug; 39(17):3409-11. PubMed ID: 8765525
[TBL] [Abstract][Full Text] [Related]
7. N,S-bis-fluorenylmethoxycarbonylglutathione: a new, very potent inhibitor of mammalian glyoxalase II.
Elia AC; Chyan MK; Principato GB; Giovannini E; Rosi G; Norton SJ
Biochem Mol Biol Int; 1995 Apr; 35(4):763-71. PubMed ID: 7627127
[TBL] [Abstract][Full Text] [Related]
8. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
[TBL] [Abstract][Full Text] [Related]
9. S-(N-aryl-N-hydroxycarbamoyl)glutathione derivatives are tight-binding inhibitors of glyoxalase I and slow substrates for glyoxalase II.
Murthy NS; Bakeris T; Kavarana MJ; Hamilton DS; Lan Y; Creighton DJ
J Med Chem; 1994 Jul; 37(14):2161-6. PubMed ID: 8035422
[TBL] [Abstract][Full Text] [Related]
10. Role of hydrophobic interactions in binding S-(N-aryl/alkyl-N-hydroxycarbamoyl)glutathiones to the active site of the antitumor target enzyme glyoxalase I.
Kalsi A; Kavarana MJ; Lu T; Whalen DL; Hamilton DS; Creighton DJ
J Med Chem; 2000 Oct; 43(21):3981-6. PubMed ID: 11052803
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of glyoxalase I by the enediol mimic S-(N-hydroxy-N-methylcarbamoyl)glutathione. The possible basis of a tumor-selective anticancer strategy.
Hamilton DS; Creighton DJ
J Biol Chem; 1992 Dec; 267(35):24933-6. PubMed ID: 1459997
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis and Biological Evaluation of Potent Human Glyoxalase I Inhibitors.
Jin T; Zhai J; Liu X; Yue Y; Huang M; Li Z; Ni C; Deng Q; Sang Y; Yao Z; Zhang H; Hu X; Zheng ZB
Chem Pharm Bull (Tokyo); 2017 May; 65(5):455-460. PubMed ID: 28320998
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic activities of Mannich bases of chalcones and related compounds.
Dimmock JR; Kandepu NM; Hetherington M; Quail JW; Pugazhenthi U; Sudom AM; Chamankhah M; Rose P; Pass E; Allen TM; Halleran S; Szydlowski J; Mutus B; Tannous M; Manavathu EK; Myers TG; De Clercq E; Balzarini J
J Med Chem; 1998 Mar; 41(7):1014-26. PubMed ID: 9544201
[TBL] [Abstract][Full Text] [Related]
14. Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells.
Sakamoto H; Mashima T; Sato S; Hashimoto Y; Yamori T; Tsuruo T
Clin Cancer Res; 2001 Aug; 7(8):2513-8. PubMed ID: 11489834
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of glyoxalase I: the first low-nanomolar tight-binding inhibitors.
More SS; Vince R
J Med Chem; 2009 Aug; 52(15):4650-6. PubMed ID: 19610604
[TBL] [Abstract][Full Text] [Related]
16. Reversal of anticancer drug resistance by COTC based on intracellular glutathione and glyoxalase I.
Kamiya D; Uchihata Y; Ichikawa E; Kato K; Umezawa K
Bioorg Med Chem Lett; 2005 Feb; 15(4):1111-4. PubMed ID: 15686923
[TBL] [Abstract][Full Text] [Related]
17. A metabolically stable tight-binding transition-state inhibitor of glyoxalase-I.
More SS; Vince R
Bioorg Med Chem Lett; 2006 Dec; 16(23):6039-42. PubMed ID: 16997560
[TBL] [Abstract][Full Text] [Related]
18. Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester.
Nakajima T; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Abe T; Kato J; Sakon K; Naniwa Y; Tanabe H; Niitsu Y
J Pharmacol Exp Ther; 2003 Sep; 306(3):861-9. PubMed ID: 12805482
[TBL] [Abstract][Full Text] [Related]
19. Design and in vivo analysis of potent non-thiol inhibitors of farnesyl protein transferase.
Anthony NJ; Gomez RP; Schaber MD; Mosser SD; Hamilton KA; O'Neil TJ; Koblan KS; Graham SL; Hartman GD; Shah D; Rands E; Kohl NE; Gibbs JB; Oliff AI
J Med Chem; 1999 Aug; 42(17):3356-68. PubMed ID: 10464022
[TBL] [Abstract][Full Text] [Related]
20. Peptide-bond modified glutathione conjugate analogs modulate GSTpi function in GSH-conjugation, drug sensitivity and JNK signaling.
Burg D; Riepsaame J; Pont C; Mulder G; van de Water B
Biochem Pharmacol; 2006 Jan; 71(3):268-77. PubMed ID: 16337611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
